Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection.
Tsou HH, Yang HC, Hsiao CF, Hsiung CA, Liu TW, Chuang MH, Wu HY, Hsu YT, Tsui CW, Chen PJ, Cheng AL, Hsu C; Taiwan Cooperative Oncology Group.
Tsou HH, et al. Among authors: yang hc.
J Formos Med Assoc. 2020 Jan;119(1 Pt 2):335-344. doi: 10.1016/j.jfma.2019.05.027. Epub 2019 Jun 22.
J Formos Med Assoc. 2020.
PMID: 31235201
Free article.